Balloon Elution and Late Loss Optimization (BELLO) Study (BELLO)
Balloon Elution and Late Loss Optimization (BELLO) Study: A Multicentre Randomized Study of the IN.PACT Falcon™ Paclitaxel Drug-eluting Balloon to Reduce Restenosis in Small Coronary Vessels
Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
This NA trial investigates Coronary Artery Disease and is currently ongoing. Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Unknown Status NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
For direct contact, visit the study record on ClinicalTrials.gov .